Challenge
Formulation research, clinical data and validated manufacturing systems sat on networks with limited segmentation, and the company needed to protect intellectual property while keeping regulated systems stable.
Approach
We classified sensitive research and clinical data, applied data loss prevention to the channels that mattered, segmented validated and manufacturing systems with change-controlled rules, and rehearsed an incident response plan with the quality and legal teams.
Outcome
Typical outcomes: clearer protection for crown-jewel data, reduced blast radius if a system is compromised, and security changes that respect validation and quality processes.
This is an anonymised, representative scenario based on the type of work we do in this sector. It does not describe a specific client or guarantee a specific result.